Aspen Pharmacare Holdings Ltd (APNJ.J)
26 Sep 2017
JOHANNESBURG, Sept 14 South Africa's Aspen Pharmacare expanded its anaesthetic drugs portfolio with a $766 million deal with AstraZeneca as it focuses on injectibles rather than making tablets.
JOHANNESBURG, Sept 14 South Africa's Aspen Pharmacare reported a 46 percent rise in full-year profit, buoyed by a revenue boost from an anaesthetics portfolio acquired from AstraZeneca and GlaxoSmithKline, the company said on Thursday.
* RAISED NORMALISED HEADLINE EARNINGS PER SHARE ("NHEPS") BY 16% TO 1 463 CENTS IN YEAR ENDED 30 JUNE 2017.
JOHANNESBURG, Aug 30 South African drugmaker Aspen Pharmacare said on Wednesday that it expects full-year profit to climb by as much as 48 percent from last year when it was hit by a writedown on its Venezuelan business.
* SEES FY NEHPS AT 1428.0 CENTS PER SHARE TO 1491.2 CENTS PER SHARE, UP 13 PERCENT - 18 PERCENT
PRETORIA South Africa's competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency's chief said on Tuesday.
* Aspen denies any wrong doing, committed to constructive engagement
* Announcement that SACC will be investigating co for suspected abuse of dominance in respect of provision of cancer medication in South Africa
PRETORIA, June 13 South Africa's competition watchdog has launched an investigation into three pharmaceutical companies suspected of charging excessively for cancer medicines, the agency's head Tembinkosi Bonakele said on Tuesday.
LUXEMBOURG, June 6 French drugmaker Servier urged an EU court on Tuesday to slash a 331 million euro ($372 million) antitrust fine, saying regulators had committed multiple errors when they ruled against the company's pay-for-delay deals with generic rivals three years ago.